Florida Precision Oncology, A Division of 21st Centry Oncology — Fort Myers, Florida

Florida Precision Oncology, A Division of 21st Centry Oncology is a clinical research site located in Fort Myers, Florida, United States 33907.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Florida Precision Oncology, A Division of 21st Centry Oncology has participated in 1 clinical trials.

Therapeutic areas: Neoplasms, Coronavirus.

Sponsors: American Society of Clinical Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fort Myers

Browse all research sites in Florida · View every site in Fort Myers

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Florida Precision Oncology, A Division of 21st Centry Oncology?

Florida Precision Oncology, A Division of 21st Centry Oncology has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Florida Precision Oncology, A Division of 21st Centry Oncology conducted?

Florida Precision Oncology, A Division of 21st Centry Oncology has 1 clinical trials on record. Their work covers Neoplasms, Coronavirus.

Is Florida Precision Oncology, A Division of 21st Centry Oncology accredited by Crixeo Clinical Trials?

Florida Precision Oncology, A Division of 21st Centry Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Florida Precision Oncology, A Division of 21st Centry Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.